BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN BEGIN:VEVENT DESCRIPTION:DESCRIPTION/OVERVIEWThe Cleveland Clinic Metabolic Dysfunction- Associated Steatohepatitis &ldquo\;MASH&rdquo\; Conference is the first tr uly multidisciplinary educational summit dedicated to MASH care. While pri or conferences have focused primarily on gastroenterology and hepatology a udiences\, this event brings together a broad range of specialties &ndash\ ; including hepatology\, transplant surgery\, endocrinology\, bariatric su rgery\, cardiology\, and oncology &ndash\; to address the entire spectrum of disease and the whole patient.Attendees will gain insights spanning ear ly metabolic dysfunction to advanced liver disease\, organ failure\, and t ransplantation\, with a focus on collaborative\, patient-centered approach es that reflect the future of MASH care.FEATURED TOPICSMASLD/MASH &ndash\; Burden\, Diagnosis\, and Clinical ImplicationsTreatment of MASH Across th e Disease SpectrumTranslational Science and Clinical Research in MASHTrans plant Candidacy\, Risk Stratification\, and Outcomes in MASHComplex and Mu lti-Organ Transplant Decision-Making in MASHMASH and Cancer (HCC\, CCA)Non -CME Hands On SymposiumWHO SHOULD ATTENDThis course is designed for gastro enterologists\, hepatologists\, bariatric\, transplant\, and general surge ons\, as well as endocrinologists\, oncologists\, and primary care physici ans.EDUCATIONAL OBJECTIVESDescribe current and emerging strategies for the prevention\, screening\, diagnosis\, and treatment of MASH across the ful l disease spectrum\, from early metabolic dysfunction to cirrhosis\, liver transplantation\, and post-transplant care.Apply evidence-based approache s to diagnose and manage coexisting cardiometabolic diseases\, including t ype 2 diabetes\, dyslipidemia\, and cardiovascular disease with particular attention to reducing major adverse cardiovascular events (MACE)\, the le ading cause of death in patients with MASH.Identify critical knowledge gap s and outline future directions in MASH research\, policy\, and clinical p ractice\, emphasizing the need for cross-disciplinary collaboration and in novation.Evaluate integrated care delivery models that combine medical\, s urgical\, behavioral digital (AI based)\, and value-based approaches to im prove access\, equity\, and outcomes in MASH&mdash\;with focused attention to high-risk populations such as living liver donors with obesity and MAS LD\, patients with severe obesity and decompensated cirrhosis undergoing t ransplant\, individuals requiring combined cardiothoracic and liver transp lantation\, and those with MASH-HCC beyond conventional transplant criteri a. DTEND;VALUE=DATE:20260816 DTSTAMP:20260916T185158Z DTSTART;VALUE=DATE:20260814 LOCATION:Ohio\,Cleveland\,Intercontinental Hotel & Conference Center SEQUENCE:0 SUMMARY:Multidisciplinary MASH Conference UID:RFCALITEM639251671188992125 X-ALT-DESC;FMTTYPE=text/html:

DESCRIPTION/OVERVIEW

The Cleveland Clinic Metabolic Dysfunction-Associated Steatohepatitis &ld quo\;MASH&rdquo\; Conference is the first truly multidisciplinary educatio nal summit dedicated to MASH care. While prior conferences have focused pr imarily on gastroenterology and hepatology audiences\, this event brings t ogether a broad range of specialties &ndash\; including hepatology\, trans plant surgery\, endocrinology\, bariatric surgery\, cardiology\, and oncol ogy &ndash\; to address the entire spectrum of disease and the whole patie nt.

Attendees will gain insights spanning early metabolic dysfunctio n to advanced liver disease\, organ failure\, and transplantation\, with a focus on collaborative\, patient-centered approaches that reflect the fut ure of MASH care.

FEATURED TOPICS

MASLD/ MASH &ndash\; Burden\, Diagnosis\, and Clinical Implications

Treatment of MASH Across the Disease Spectrum

Transla tional Science and Clinical Research in MASH

Transplant C andidacy\, Risk Stratification\, and Outcomes in MASH

Com plex and Multi-Organ Transplant Decision-Making in MASH

M ASH and Cancer (HCC\, CCA)

Non-CME Hands On Symposium

WHO SHOULD ATTEND

This course is designed for gastroenterologi sts\, hepatologists\, bariatric\, transplant\, and general surgeons\, as w ell as endocrinologists\, oncologists\, and primary care physicians.

EDUCATIONAL OBJECTIVES

Describe current and e merging strategies for the prevention\, screening\, diagnosis\, and treatm ent of MASH across the full disease spectrum\, from early metabolic dysfun ction to cirrhosis\, liver transplantation\, and post-transplant care.

Apply evidence-based approaches to diagnose and manage coexi sting cardiometabolic diseases\, including type 2 diabetes\, dyslipidemia\ , and cardiovascular disease with particular attention to reducing major a dverse cardiovascular events (MACE)\, the leading cause of death in patien ts with MASH.

Identify critical knowledge gaps and outlin e future directions in MASH research\, policy\, and clinical practice\, em phasizing the need for cross-disciplinary collaboration and innovation.

Evaluate integrated care delivery models that combine medic al\, surgical\, behavioral digital (AI based)\, and value-based approaches to improve access\, equity\, and outcomes in MASH&mdash\;with focused att ention to high-risk populations such as living liver donors with obesity a nd MASLD\, patients with severe obesity and decompensated cirrhosis underg oing transplant\, individuals requiring combined cardiothoracic and liver transplantation\, and those with MASH-HCC beyond conventional transplant c riteria.

END:VEVENT END:VCALENDAR